Cystectomy and stage IV disease significantly increased the risk of VTE in BC patients; adjusted odds ratio (OR); OR 2.88 (95% CI 1.63–5.07), p < 0.001 and OR 4.41 (95% CI 1.85–10.50), p = 0.002, respectively, while chemotherapy was found to have borderline significance as a risk factor; OR 2.56 (95% CI 1.03–6.32), p = 0.041.
Although there was a trend toward lower post‐operative bleeding in the VET group, this difference did not reach statistical significance (9.4% in VET and 16.8% in SCT, RR = 0.51, p = 0.12, 95%CI 0.33‐1.13).
Patients whose treatment adhered to the protocol post‐TEG showed a trend towards lower mean blood loss (2024 vs 2989 ml, p = 0.27), reduced mean RBC transfusion (1.45 vs 2.0 units, p = 0.27) and reduced FFP transfusion (0.91 vs 1.83, p = 0.15), however, none of the results reached statistical significance.
Methods: Following evaluation by standard coagulations test and bleeding assessment tool (BAT) score, patients with BUC and a highly significant BAT score >9 were enrolled.